Holly Baker

430 total citations
41 papers, 136 citations indexed

About

Holly Baker is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Holly Baker has authored 41 papers receiving a total of 136 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Holly Baker's work include Lung Cancer Treatments and Mutations (5 papers), Intimate Partner and Family Violence (4 papers) and Adolescent Sexual and Reproductive Health (4 papers). Holly Baker is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Intimate Partner and Family Violence (4 papers) and Adolescent Sexual and Reproductive Health (4 papers). Holly Baker collaborates with scholars based in United Kingdom, United States and Australia. Holly Baker's co-authors include John Bamford, Theresa M. Marteau, Kai Uus, Rachel A. Crockett, Leslie Clarke, Stan L. Albrecht, Carol A. Bryant, Joan Flocks, Paul Monaghan and Victoria Hodgetts Morton and has published in prestigious journals such as The Lancet Oncology, Environmental Health Perspectives and Patient Education and Counseling.

In The Last Decade

Holly Baker

36 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly Baker United Kingdom 7 26 26 26 25 15 41 136
Alex Beny Israel 7 22 0.8× 35 1.3× 42 1.6× 102 4.1× 29 1.9× 12 243
Lauren Grant United States 8 16 0.6× 10 0.4× 17 0.7× 25 1.0× 8 0.5× 21 216
Ingeborg Blancquaert Canada 9 42 1.6× 59 2.3× 21 0.8× 16 0.6× 26 1.7× 12 292
Sandra Suther United States 6 24 0.9× 41 1.6× 36 1.4× 39 1.6× 37 2.5× 20 278
Rona Sonabend United States 8 21 0.8× 73 2.8× 26 1.0× 26 1.0× 26 1.7× 23 266
Marian J. Gilmore United States 10 23 0.9× 76 2.9× 61 2.3× 30 1.2× 14 0.9× 25 267
Shauna McManus United States 9 25 1.0× 37 1.4× 30 1.2× 57 2.3× 13 0.9× 35 195
Laurie Green Canada 8 28 1.1× 10 0.4× 16 0.6× 16 0.6× 31 2.1× 10 224
Sarah Lyons United States 10 63 2.4× 23 0.9× 19 0.7× 33 1.3× 10 0.7× 15 253
Tracy L. Jackson United States 8 25 1.0× 19 0.7× 19 0.7× 11 0.4× 65 4.3× 26 278

Countries citing papers authored by Holly Baker

Since Specialization
Citations

This map shows the geographic impact of Holly Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Baker more than expected).

Fields of papers citing papers by Holly Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Baker. The network helps show where Holly Baker may publish in the future.

Co-authorship network of co-authors of Holly Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Baker. A scholar is included among the top collaborators of Holly Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Baker. Holly Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caleo, Grazia, Kamalini Lokuge, Jane Greig, et al.. (2024). Methodological issues of retrospective surveys for measuring mortality of highly clustered diseases: case study of the 2014–16 Ebola outbreak in Bo District, Sierra Leone. Global Health Action. 17(1). 2331291–2331291. 1 indexed citations
3.
Boyce, Sabrina C., Alexandra M. Minnis, Julianna Deardorff, et al.. (2023). Measuring social norms of intimate partner violence to exert control over wife agency, sexuality, and reproductive autonomy: an item response modelling of the IPV-ASRA scale. Reproductive Health. 20(1). 90–90. 2 indexed citations
5.
Gopalakrishnan, Lakshmi, Stefano Bertozzi, Patrick T. Bradshaw, et al.. (2023). The Role of Gender Norms on Intimate Partner Violence Among Newly Married Adolescent Girls and Young Women in India: A Longitudinal Multilevel Analysis. Violence Against Women. 31(1). 182–205. 1 indexed citations
6.
Baker, Holly. (2023). Research in Brief. ˜The œLancet. Gastroenterology & hepatology. 8(11). 972–972.
7.
Baker, Holly, et al.. (2021). Comparison of visual and computerised antenatal cardiotocography in the prevention of perinatal morbidity and mortality. A systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 263. 33–43. 8 indexed citations
8.
Kalsi, Tania, et al.. (2020). Functional recovery in older women undergoing surgery for gynaecological malignancies: A systematic review and narrative synthesis. Journal of Geriatric Oncology. 11(7). 1087–1095. 5 indexed citations
9.
Baker, Holly. (2020). Research in brief. ˜The œLancet. Gastroenterology & hepatology. 5(4). 340–340. 1 indexed citations
10.
Baker, Holly. (2016). Trastuzumab biosimilar shows potential for breast cancer. The Lancet Oncology. 18(1). e4–e4. 1 indexed citations
11.
Baker, Holly. (2016). Sunitinib as adjuvant therapy for renal cell carcinoma. The Lancet Oncology. 17(11). e485–e485. 3 indexed citations
12.
Baker, Holly. (2016). Second cancer risk for Hodgkin's lymphoma survivors. The Lancet Oncology. 17(2). e50–e50. 1 indexed citations
13.
Baker, Holly. (2016). Daratumumab improves survival in multiple myeloma. The Lancet Oncology. 17(11). e480–e480. 4 indexed citations
14.
Baker, Holly. (2015). High HLA-DP expression and graft-versus-host disease. The Lancet Oncology. 16(9). e434–e434. 1 indexed citations
15.
Baker, Holly. (2015). 21-gene assay identifies patients who can avoid chemotherapy. The Lancet Oncology. 16(15). e531–e531. 3 indexed citations
16.
Baker, Holly. (2015). Docetaxel for hormone-sensitive metastatic prostate cancer. The Lancet Oncology. 16(9). e432–e432. 3 indexed citations
17.
Baker, Holly. (2015). Vemurafenib for relapsed or refractory hairy-cell leukaemia. The Lancet Oncology. 16(13). e484–e484. 1 indexed citations
18.
Baker, Holly. (2013). Onartuzumab benefits patients with MET-positive NSCLC. The Lancet Oncology. 14(12). e495–e495. 1 indexed citations
19.
Baker, Holly, Rachel A. Crockett, Kai Uus, John Bamford, & Theresa M. Marteau. (2007). Why don't health professionals check patient understanding? A questionnaire-based study. Psychology Health & Medicine. 12(3). 380–385. 12 indexed citations
20.
Baker, Holly, Kai Uus, John Bamford, & Theresa M. Marteau. (2003). Increasing knowledge about a screening test: preliminary evaluation of a structured, chart-based, screener presentation. Patient Education and Counseling. 52(1). 55–59. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026